ADRB2 and posterior cortical atrophy: If this were to be confirmed in human PCa cells, then it would become necessary to assess the level of ADRB2 expression prior to ADT treatment and taken into consideration for additional treatment such as ADRB2 inhibitors (ADRB2i).